• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 26, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2125-12
Classification Class II
Code Info 4210087445, 4210086539, 4210085985, 4210084967, 4210084427, 4210083400, 4210082857, 4210081860, 4210081310, 4210080472, 4210080007, 4210078342, 4210077910, 4210076935, 4210076450, 4210075537, 4210075213, 4210074270, 4210073891, 4210073088, 4210072653, 4210071612, 4210071224, 4210070322, 4210069960, 4210069078, 4210068483, 4210067206, 4210066479, 4210065781, 4210064777, 4210063218, 4210062738, 4210061939, 4210061350, 4210060514, 4210060086, 4210059008, 4210058606, 4210057603, 4210057170, 4210055403, 4210054727, 4210053865, 04210053444
Product Distributed Qty 45 units
Reason For Recall Blood products, collected from a donor who did not have a physical examination, were distributed.

Event Detail

Event Id 42835
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma Inc
City Omaha
State NE
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2006-07-19
Initial Firm Notification of Consignee or Public Other
Distribution Pattern Germany, Switzerland, IL, NC
-
-